Share Price:

APNASPENAspen Pharmacare Hldgs1950097 (0.50%)

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform to be released on 4 March 2024.

Media Coverage

4-7 December 2023
Aspen | Sandoz Announcement
The Aspen and Sandoz transactions mark a significant shift in the pharmaceutical landscape. Aspen's acquisition of Sandoz's thrombosis business reflects a strategic move, consolidating expertise and expanding market presence. The deal positions Aspen for sustained growth while enhancing its global pharmaceutical footprint.

Newzroom Afrika

Stephen Saad | Xolani Mbanjwa

4 December 2023

The interview with Xolani Mbanjwa and Stephen Saad offered key insights into the Aspen | Sandoz announcement. Their discussion illuminated the strategic implications of the deal, emphasizing its impact on Aspen’s position in the pharmaceutical landscape and potential benefits for stakeholders.

eNCA: Night News

Sean Capazorio | Anlie Hattingh
5 December 2023

The eNCA Night News interview featuring Sean Capazorio and Anlie Hattingh provided a comprehensive exploration of key financial insights. Their discussion delved into market trends, offering viewers valuable perspectives on navigating the dynamic landscape of business and finance.

Business Day TV – News Leader

Sean Capazorio | Noluthando Mthonti-Mlambo

6 December 2023

Aspen and Sandoz have inked a near R2 billion deal. For that price tag, Aspen will buy Sandoz’s Chinese business. In return, Sandoz will take on four anaesthetic products that Aspen sells in Europe. Business Day TV unpacked the deal in greater details with Aspen’s Group CFO, Sean Capazorio.

CNBC Africa – Closing Bell

Sean Capazorio | Tania Habimana

7 December 2023

Sean Capazorio provided a high level understanding of the Sandoz agreements particularly the potential it offers for Aspen’s expansion in China given the acquisition of the full business from Sandoz in this territory. Deeper discussion touched on Aspen’s strong footprint in emerging markets with China being the Group’s beachhead in Asia.

Power 98.7: Power Business

Sean Capazorio | Noluthando Mthonti-Mlambo

4 December 2023

In the Power Business interview with Sean Capazorio and Noluthando Mthonti-Mlambo, dynamic insights emerged, outlining strategic visions for the energy sector. Their dialogue illuminated key trends, emphasizing sustainable practices and innovation in power management.

702: The Money Show

Sean Capazorio | Motheo Khoaripe

4 December 2023

The Money Show interview with Sean Capazorio and Motheo Khoaripe provided a compelling discussion on financial strategies and market trends. Their insights into investment and economic outlooks offered valuable perspectives for listeners navigating the ever-changing financial landscape.

SAfm Market Update – Moneyweb

Sean Capazorio | Jimmy Moyaha

7 December 2023

Sean Capazorio and Jimmy Moyaha discussed Aspen’s agreements with Sandoz as well as the Group’s recent announcements and opportunities for growth and diversification.

19-20 September 2023
Aspen | Novo Nordisk Announcement
The Aspen Novo Nordisk announcement signifies a pivotal moment in pharmaceutical collaboration, promising innovative solutions in healthcare. It has the potential to reshape the industry and improve patient outcomes globally.

CNBC Africa: Closing Bell

Stephen Saad | Tania Habimana

The CNBC Closing Bell interview with Stephen Saad and Tania Habimana provided valuable insights into the impactful Novo Nordisk announcement, shedding light on its potential implications for the healthcare industry and global markets.

eNCA

Stephen Saad | Sally Burdett

The eNCA interview featuring Stephen Saad and Sally Burdett delved into the Aspen Novo Nordisk announcement, offering a comprehensive analysis of its significance within the pharmaceutical landscape and its potential ramifications for stakeholders worldwide.

702: The Money Show & Cape Talk Radio

Stavros Nicolaou | Bruce Whitfield

The Money Show with Bruce Whitfield and Stavros Nicolaou provided valuable insights into the Aspen-Novo Nordisk announcement, underscoring its significance in pharmaceutical collaboration. Their discussion shed light on the potential for healthcare advancements and business opportunities arising from this partnership.

702 Breakfast with Bongani Bingwa

Breakfast News Coverage

Bongani Bingwa’s Morning News on 702 delivered a comprehensive breakdown of the Novo Nordisk deal, emphasizing its impact on healthcare and the local economy. 

Cape Talk 567

The Morning Review with Lester Kiewit

Cape Talk 567’s Morning News provided a thorough analysis of the Novo Nordisk deal, offering listeners a clear understanding of its implications for healthcare and the broader market. 

30 August 2023
Aspen 2023 Annual Results
Aspen's 2023 annual results showcased robust financial performance, driven by strategic expansion and innovation. Revenue growth, profit margins, and global market presence all reflected the company's commitment to excellence and its pivotal role in the pharmaceutical industry.

CNBC Africa: Closing Bell

Stephen Saad | Tania Habimana

The CNBC Closing Bell interview with Stephen Saad and Tania Habimana showcased their visionary insights into healthcare and emerging markets, offering a compelling glimpse into the future of pharmaceuticals and sustainable business in Africa.

Newzroom Afrika

Stephen Saad | Xolani Mbanjwa

The Newzroom Afrika interview featuring Stephen Saad and Xolani Mbanjwa was a dynamic exchange of ideas, delving into critical topics shaping South Africa’s economy and healthcare sector, highlighting innovative solutions and future prospects.

eNCA: Moneydesk

Stephen Saad | Melissa Tighy

The eNCA Moneydesk interview with Stephen Saad and Melissa Tighy was an enlightening discussion on entrepreneurship, investment, and economic trends. Their insights provided valuable perspectives for viewers keen on financial success.

Business Day TV – The Close: News Leader

Stephen Saad | Zinathi Gquma

Business Day TV’s The Close, News Leader with Stephen Saad and Zinathi Gquma delivered an informative discussion on current market trends and business developments, shedding light on South Africa’s economic outlook with expertise and clarity.

702: The Money Show & Cape Talk Radio

Stephen Saad | Motheo Khoaripe

The Money Show with Motheo Khoaripe and Stephen Saad delivered a captivating dialogue on investment strategies and economic resilience. Their expertise and practical advice offered viewers valuable financial wisdom.

Moneyweb & RSG

Stephen Saad | Ryk van Niekerk

The Moneyweb and RSG interview featuring Stephen Saad and Ryk van Niekerk was a profound discussion, shedding light on investment strategies and economic trends. Their insights were a valuable resource for those looking to navigate the financial landscape effectively.

Power 98.7: Power Business

Sean Capazorio | Noluthando Mthonti-Mlambo

The Power 98.7 Power Business interview with Sean Capazorio and Noluthando Mthonti-Mlambo was an engaging exploration of business dynamics and innovation. Their insights offered a fresh perspective on success in the ever-evolving corporate world.

7 May 2023
Big Pharma and Intra Africa Trade
The year 2023 marked a significant turning point for the pharmaceutical industry in Africa, as the Big Pharma and Intra-Africa Trade gained momentum. This transformative initiative aimed to bolster intra-African trade in the pharmaceutical sector, promoting local production, access to affordable medicines, and sustainable healthcare development.

CNN Connecting Africa

Stephen Saad | Eleni Giokos

This CNN Connecting Africa interview provided a platform for thought-provoking conversations on the pharmaceutical industry’s role in driving intra-Africa trade and healthcare development. By exploring collaborative approaches, fostering innovation, and addressing regulatory challenges, Africa can unlock its immense potential in pharmaceutical manufacturing, contribute to improved healthcare outcomes, and promote economic growth across the continent.
17 - 18 April 2023
African Continental Free Trade Area Business Forum
The 2023 African Continental Free Trade Area (AfCFTA) Business Forum emerged as a pivotal platform for unlocking the immense economic potential of the African continent. Gathering business leaders, policymakers, and stakeholders from across Africa, the forum focused on exploring opportunities and strategies to harness the power of the AfCFTA agreement.

 eNCA South Africa

Stavros Nicolaou | Devan Murguran

In a compelling interview on eNCA South Africa, Stavros Nicolaou and Devan Murguran engaged in an enlightening discussion. Their expert insights and thought-provoking dialogue shed light on the South African business landscape, offering viewers valuable perspectives on investment opportunities, challenges, and strategies for driving economic growth.

SABC News

Stavros Nicolaou | Katlego Legodi

SABC News featured an insightful conversation between Stavros Nicolaou and Katlego Legodi. The interview delved into key economic development, investment opportunities, and healthcare topics. Their exchange provided valuable insights, giving viewers a deeper understanding of the current business landscape and the potential for growth and innovation in South Africa.

Newzroom Afrika

Stavros Nicolaou | Ntokozo Khumalo

Newzroom Afrika conducted a thought-provoking interview with Stavros Nicolaou and Ntokozo Khumalo. The discussion covered various topics, including economic trends, investment prospects, and healthcare. Nicolaou’s expertise and Khumalo’s incisive questions gave viewers valuable insights into the South African business landscape and its implications for the country’s growth and development.

SaFM: Market Update for Moneyweb

Stavros Nicolaou | Fifi Peters

SaFM’s Market Update for Moneyweb featured a dynamic discussion between Stavros Nicolaou and Fifi Peters on the African Continental Free Trade Area Business Forum. The interview provided valuable insights on the forum’s outcomes, highlighting the potential for increased trade, collaboration, and economic growth in Africa.

SABC Channel Africa: Africa in Business

Stavros Nicolaou | Lulu Gaboo

SABC’s Africa in Business featured a discussion between Stavros Nicolaou and Lulu Gaboo on investment prospects, economic patterns, and healthcare in Africa. They offered insightful angles on promoting economic progress and establishing business growth throughout the continent.

13 April 2023
South Africa Investment Conference
The 2023 South Africa Investment Conference showcased the country's commitment to attracting investment, driving sustainable development, and fostering economic growth. By presenting diverse investment opportunities, promoting investor-friendly policies, and emphasizing inclusivity, South Africa solidified its position as an attractive destination for local and international investors. The outcomes of this conference have the potential to stimulate job creation, foster innovation, and contribute to the overall prosperity of the nation.

SABC News

Stavros Nicolaou | Liabo Setho, Economics Reporter

SABC News Economics Reporter Liabo Setho engaged in an insightful conversation with Aspen’s Stavros Nicolaou at the highly anticipated 2023 South Africa Investment Conference. As energy challenges took centre stage during the event, the discussion shed light on Aspen’s perspective and strategies in addressing this critical issue.

eNCA

Stavros Nicolaou | Gareth Edwards

eNCA’s Gareth Edwards interviewed Stavros Nicolaou post the South Africa Investment Conference. The interview delved into various aspects of the conference, shedding light on the investment landscape in South Africa and the opportunities it presents. During the interview, Stavros Nicolaou, shared his perspectives on the investment climate in South Africa.

CNBC Africa

Stavros Nicolaou | Zanele Morrisson

CNBC’s Zanele Morrisson engaged in a compelling interview with Stavros Nicolaou at the South Africa Investment Conference, providing valuable insights into the country’s investment landscape. The interview delved into various topics, offering a comprehensive overview of the opportunities and challenges for investment in South Africa.

SaFM: Update at Noon

Stavros Nicolaou | Sakinna Kamwendo

In a recent episode of SaFM’s “Update at Noon,” host Sakinna Kamwendo conducted an engaging interview with Stavros Nicolaou. The interview provided listeners with valuable insights into the South African economy, investment trends, and strategies for driving growth.

17 March 2023
South Africa - Tanzania Business Forum Outcomes
The 2023 South Africa - Tanzania Business Forum, held in a spirit of collaboration and mutual growth, brought together key stakeholders from both countries to explore avenues for economic cooperation and forge stronger ties. The outcomes of this highly anticipated event could shape the future of business relations between South Africa and Tanzania.
eNCA All Angles
Stavros Nicolaou | Masego Rahlaga

eNCA’s “All Angles” featured a dynamic discussion between Stavros Nicolaou and Masego Rahlaga. The conversation delved into critical issues, offering a comprehensive view of the South African business landscape. Their insights provided valuable perspectives on economic growth, investment opportunities, and the future of various industries.

17 March 2023
Aspen 2023 Interim Results
Our 2023 Interim Results cover a comprehensive overview of Aspen's financial performance and key achievements during the first half of the financial year. Investors, industry analysts, and stakeholders use these results to gain insights into the company's growth trajectory and strategic initiatives. With a reputation for innovation and a diverse portfolio of healthcare products, Aspen's interim results are expected to provide valuable insights into the company's continued success in navigating the dynamic pharmaceutical landscape.
Business Day TV: News Leader
Stephen Saad | Zinathi Gquma

Stephen Saad and Zinathi Gquma had an engaging interview on Business Day TV’s News Leader segment. They discussed crucial business and economic matters, sharing valuable observations on industry patterns, investment techniques, and the financial forecast. It’s a must-watch for those seeking well-informed viewpoints on the business environment.

CNBC Africa

Stephen Saad | Tania Habimana

CNBC Africa hosted a discussion on business and economics with Stephen Saad and Tania Habimana. They talked about investment strategies, industry trends, and the African business landscape, offering valuable insights. Saad’s expertise and Habimana’s incisive questions provided clear understanding of key issues.

eNCA : South Africa Tonight

Stephen Saad | Sally Burdett

eNCA’s South Africa Tonight featured an interview with Stephen Saad and Sally Burdett on Aspen’s 2023 interim results, providing valuable insights into the company’s performance and achievements in a concise and informative manner.

Newzroom Afrika: NewsFeed

Stephen Saad | Xolani Mbanjwa

Newzroom Afrika’s NewsFeed featured Stephen Saad and Xolani Mbanjwa discussing Aspen’s 2023 interim results. The interview provided a concise overview of the company’s financial performance and future prospects, keeping viewers informed about Aspen’s latest developments.

The Nielsen Network: C-Suite

Stephen Saad | Bronwyn Nielsen

Stephen Saad and Bronwyn Nielsen discussed Aspen’s 2023 interim results on The Nielsen Network’s C-Suite. The interview offered a succinct overview of the company’s financial performance and strategic direction, providing valuable insights for viewers interested in Aspen’s progress.

The Money Show

Stephen Saad | Bruce Whitfield 

On The Money Show, Stephen Saad and Bruce Whitfield analysed Aspen’s 2023 interim results, offering concise insights into the company’s financial performance and strategic outlook to keep listeners informed and engaged.

SAFM: Market Update

Sean Capazorio | Fifi Peters 

SAFM’s Market Update covered Aspen’s 2023 interim results, with Sean Capazorio and Fifi Peters discussing the company’s financial status and future plans. The interview provided important insights for listeners.

Power 98.7: Power Business

Sean Capazorio | Jimmy Moyaha 

Aspen’s interim results for 2023 were discussed on Power 98.7’s Power Business segment by Sean Capazorio and Jimmy Moyaha, providing valuable insights into the company’s financial performance and strategic outlook.

CNBC Africa

Stephen Saad | Godfrey Mutizwa

CNBC Africa’s Captains of Industry hosted an engaging conversation between Stephen Saad and Godfrey Mutizwa. The interview provided concise insights into business trends, investment strategies, and industry outlooks, offering valuable perspectives from these influential business leaders.

18 February 2023
Aspen SED Initiatives | Earthquakes in Turkey and Syria
Aspen has demonstrated its commitment to corporate social responsibility by helping those affected by the devastating earthquakes in Turkey and Syria. Recognising the urgent need for medical aid, Aspen donated essential medicines, medical supplies, and equipment to local hospitals and relief organisations. These contributions played a crucial role in addressing the immediate healthcare needs of the affected communities, providing relief and support to those impacted by the earthquakes.

eNCA

Stavros Nicolaou | Tumelo Mothotoane

eNCA’s interview with Stavros Nicolaou and Tumelo Mothotoane on the earthquakes in Syria and Turkey was a poignant and informative discussion. The conversation explored the impact of the earthquakes on the affected regions, humanitarian efforts, and the importance of global collaboration in providing support and aid. Nicolaou and Mothotoane’s insights shed light on the challenges faced and the steps needed to help those affected rebuild their lives and communities.

12-13 December 2022
Aspen, Gates Foundation & CEPI Commitments for Vaccine Access for Africa
The Aspen-Gates-CEPI commitment signals a transformative step towards vaccine equity in Africa. By leveraging Aspen's production capabilities and the Gates Foundation-CEPI support, the initiative aims to increase vaccine access, bolster manufacturing capacity, and address healthcare disparities.

Newzroom Afrika

Stavros Nicolaou | Xolani Mbanjwa

The Newzroom Afrika interview with Xolani Mbanjwa and Stavros Nicolaou delved into the Aspen-Gates-CEPI announcement, highlighting its global health impact. Their insights on vaccine access and production showcased a pivotal collaboration that aims to address pressing healthcare challenges on a broad scale.

702 and Cape Talk: The Money Show

Stavros Nicolaou | Bruce Whitfiled

The Money Show interview with Stavros Nicolaou and Bruce Whitfield provided a deep dive into the Aspen-Gates-CEPI announcement, unraveling its implications for global health and vaccine accessibility. Their discussion shed light on the collaborative efforts shaping a transformative response to healthcare challenges.

Moneyweb: Market Update

Stavros Nicolaou | Fifi Peters

The Moneyweb Market Update interview with Stavros Nicolaou and Fifi Peters delved into the Aspen-Gates-CEPI announcement, offering insights on its significance in global health and pharmaceutical advancements. Their discussion highlighted the collaborative efforts driving positive change in vaccine accessibility and production.

SAfm: Beyond the Headlines

Stavros Nicolaou | Aldrin Sampear

The SAfm: Beyond the Headlines interview with Stavros Nicolaou and Aldrin Sampear provided a nuanced exploration of the Aspen-Gates-CEPI announcement. Their discussion illuminated the strategic collaboration’s potential impact on vaccine equity and global health, contributing valuable insights to public discourse.

8 November 2022
Aspen closes EUR1.26 billion syndicated Loan Facilities
Aspen's successful closure of EUR1.26 billion syndicated loan facilities marks a strategic financial milestone. This substantial funding reinforces Aspen's liquidity and positions the company for continued growth and innovation in the pharmaceutical industry on a global scale.

CNBC Africa

Sean Capazorio | Tania Habimana

Sean Capazorio and Tani Habimana discussed the EUR1.26 billion syndicated loan facilities, shedding light on strategic financial moves. Their insights emphasised Aspen’s financial strength and its ability to navigate global markets effectively.

31 August 2022
Aspen 2022 Annual Results & Serum Institute Announcement
Aspen's 2022 annual results showcased robust performance, and the Serum Institute announcement marked a strategic milestone. The collaboration signifies Aspen's pivotal role in advancing global vaccine production, contributing to enhanced healthcare accessibility and reinforcing the company's position as a key player in the pharmaceutical landscape.

Business Day TV: News Leader

Stephen Saad | Zinati Gquma

Zinati Gquma and Stephen Saad discussed Aspen’s impressive double-digit earnings growth. Their insights shed light on the factors driving the company’s success, providing valuable perspectives for investors and industry observers.

Newzroom Afrika

Stephen Saad | Xolani Mbanjwa

The Newzroom Afrika interview on August 31, 2022, featuring Xolani Mbanjwa and Stephen Saad, delved into critical business topics. Their discussion covered market dynamics, corporate strategies, and economic insights, offering viewers valuable perspectives on navigating the dynamic business landscape.

CNBC: The Closing Bell

Stephen Saad | Tania Habimana

Tania Habimana and Stephen Saad engaged in a insightful discussion. Their dialogue explored key financial trends, corporate strategies, and market dynamics, providing valuable insights for viewers navigating the evolving business landscape.

eNCA

Stephen Saad | Devan Murugan

This interview highlighted Aspen’s pivotal 10-year agreement with Serum Institute. Their discussion likely unveiled the strategic implications of this collaboration, emphasizing Aspen’s role in advancing pharmaceutical capabilities and global health initiatives.

The Nielsen Network’s C-Suite

Stephen Saad | Bronwyn Nielsen

On The Nielsen Network’s C-Suite, Bronwyn Nielsen and Stephen Saad engaged in a compelling discussion. Their dialogue likely provided valuable insights into business strategies, industry trends, and corporate leadership, contributing to a nuanced understanding of the evolving business landscape.

SABC News: Full View

Stavros Nicolaou | Francis Herd

Francis Herd and Stavros Nicolaou delved into critical healthcare discussions. Their dialogue likely covered pharmaceutical advancements, public health initiatives, and the broader impact of strategic collaborations, offering viewers insightful perspectives on the evolving medical landscape.

SABC News: Today & Reuters

News coverage

The Aspen and Serum Institute announcement took centre stage, revealing a transformative collaboration in the pharmaceutical realm. Insights shared likely highlighted the significance of this partnership in advancing global vaccine accessibility and production capabilities.

702 and Cape Talk: The Money Show

Stephen Saad | Bruce Whitfiled

Stephen Saad and Bruce Whitfield provided in-depth perspectives on pivotal topics in the business world. Their discussion likely covered market trends, company strategies, and economic outlooks, offering valuable insights for listeners navigating the dynamic financial landscape.

BBC World Radio: Focus on Africa

Lisa Bonadonna | Bola Mosuro


BBC World Radio’s Focus on Africa with Bola Mosuro and Dr Lisa Bonadonna explored critical health issues, providing insightful discussions on medical advancements and global health initiatives, and contributing to a nuanced understanding of healthcare challenges in Africa.

28 July 2022
Aspen's Response to the World Health Organization Declaration on Monkeypox
On 23 July 2022, the WHO Director-General declared the Monkeypox outbreak a Public Health Emergency of International Concern. This critical announcement underscored the severity of the situation, prompting global attention and collaborative efforts to address and mitigate the public health crisis.

Newzroom Afrika

 Lisa Bonadonna | Stephen Grootes

On Newzroom Afrika, Stephen Grootes and Dr. Lisa Bonadonna discussed Monkeypox vaccines, providing insights into research, development, and the global health impact. Their dialogue contributed to public awareness and understanding of efforts to combat emerging infectious diseases.

702 and Cape Talk: The Money Show

Lisa Bonadonna | Bruce Whitfield

On 702 & Cape Talk: The Money Show, Bruce Whitfield and Dr. Lisa Bonadonna discussed Aspen’s response to Monkeypox being declared a Public Health Emergency of International Concern by the WHO. Their insights addressed pharmaceutical strategies, global health implications, and Aspen’s role in combating infectious diseases.

25 March 2022
Aspen presented with prestigious SAIC Business Award
The SAIC Business Awards recognise exemplary achievements and contributions in the business sector. Celebrating innovation, leadership, and excellence, these awards showcase organisations and individuals who have made significant impacts, setting industry standards and inspiring others to excel in the dynamic business landscape.

SABC News: 2022 SA Investment Conference

Stavros Nicolaou | Peter Ndoro

Aspen’s recognition with the prestigious SAIC Business Award highlights its outstanding contributions to the business landscape. This accolade reflects Aspen’s commitment to excellence and innovation, solidifying its position as a leader in the industry.

24 March 2022
Aspen pledges additional R500 million at SAIC 2022
At the 2022 SA Investment Conference, Aspen reaffirmed its commitment to South Africa with a significant R500 million pledge. This underscores the company's dedication to economic development, job creation, and advancing critical sectors, contributing to the nation's growth trajectory.

SABC News: 2022 SA Investment Conference

Stavros Nicolaou | Glorious Sefako-Musi

Glorious Sefako-Musi and Stavros Nicolaou highlighted Aspen’s substantial investments in Gqeberha, South Africa, surpassing R8 billion. Their discussion underscored Aspen’s commitment to local development and economic growth, showcasing their significant impact on the region.

SABC News: The Globe

Stavros Nicolaou | Peter Ndoro

Peter Ndoro engaged with Stavros Nicolaou on Aspen’s second SAIC pledge of R500 million. Their conversation emphasised Aspen’s ongoing commitment to socio-economic development in South Africa, showcasing corporate responsibility and positive impact on community welfare.

CNBC Africa

Stavros Nicolaou | Fifi Peters

Fifi Peters and Stavros Nicolaou discussed Aspen’s impactful Covid-19 response, focusing on vaccine roll-out in Africa. Their dialogue highlighted Aspen’s crucial role in enhancing vaccine accessibility and addressing healthcare challenges on the continent.

Euronews: Focus

Stavros Nicolaou

In this EuroNews profile video for the 4th South Africa Investment Conference, Stavros Nicolaou showcases Aspen’s commitment to investment, innovation, and economic development, contributing to the country’s growth narrative and reinforcing the company’s pivotal role in South Africa’s business landscape.

23 March 2022
Aspen donates life-saving medicines for 62 000 surgeries in Ukraine
Aspen's humanitarian effort shines as it donates life-saving medicines for 62,000 surgeries in Ukraine. This impactful gesture demonstrates Aspen's commitment to global health, providing critical support during challenging times and showcasing the pharmaceutical industry's role in contributing to international well-being.

eNCA

Stavros Nicolaou | Annika Larsen

Annika Larsen and Stavros Nicolaou highlighted Aspen’s impactful donation of medicines to Ukrainian patients. Their discussion emphasized the company’s commitment to global health and humanitarian efforts, showcasing Aspen’s corporate responsibility and positive contributions to international communities.

eNCA

Tumelo Mothotoane | Ms Liubov Abravitova

Tumelo Mothotoane and Ms. Liubov Abravitova, Ukraine Ambassador to SA, reflected on the Ukraine war one month later. Their discussion delved into the ongoing humanitarian situation, geopolitical implications, and international responses, providing viewers with critical insights into the evolving crisis.

10 March 2022
Aspen repatriates South African students from Ukraine
Aspen's collaboration with the South African Department of International Relations and Cooperation to repatriate students from Ukraine showcases a commendable public-private partnership, underscoring corporate responsibility and commitment to the well-being of South African citizens in times of crisis.

eNCA

Stavros Nicolaou | Heidi Giokos

Stavros Nicolaou welcomed 10 South African students fleeing war-stricken Ukraine at OR Tambo International Airport. The coverage highlights Aspen’s support in facilitating their safe return, showcasing corporate responsibility during international crises.

eNCA

Stavros Nicolaou | Annika Larsen

Annika Larsen and Stavros Nicolaou highlighted Aspen’s pivotal role in repatriating 25 South African students from Ukraine. Their discussion underscored Aspen’s commitment to global responsibility, contributing to the well-being and safety of citizens during challenging times.

Times Live

Vutlhari Mtonga – SA Student

In the Times Live interview, Vutlhari Mtonga, a repatriated SA student from Ukraine, shared her experiences and made a heartfelt plea to aid Ukrainian citizens. Her account shed light on the human impact of the crisis, urging collective support for those affected.

Newzroom Afrika

Zikhona Tshona engaged with Stavros Nicolaou to discuss the repatriation of SA students from Ukraine. The dialogue underscored Aspen’s role in the humanitarian effort, highlighting collaborative initiatives during times of crisis.

Stavros Nicolaou | Zikhona Tshona

8-9 March 2022
Interim Results & Aspenovax License Agreement
Aspen's 2021 Interim Results and Aspenovax License Agreement showcase financial resilience and strategic foresight. The announcement likely detailed positive outcomes, emphasizing the company's commitment to innovation and its role in advancing global healthcare through vaccine development.

The Nielsen Network: C-Suite

Stephen Saad | Bronwyn Nielsen

Stephen Saad discussed Aspen’s financial performance, strategic initiatives, and the pharmaceutical landscape, offering key insights for investors and stakeholders.

Newzroom Afrika

Stephen Saad | Xolani Mbanjwa

Aspen’s significant deal with J&J to distribute COVID-19 vaccines across Africa and its interim results took centre stage. The discussion likely explored the strategic implications of the collaboration and provided insights into Aspen’s financial performance.

eNCA: South Africa Tonight

Stephen Saad | Devan Murugan

Devan Murugan engaged in a discussion on Aspen’s interim results with Stephen Saad. The dialogue provided valuable insights into the company’s financial performance and strategic outlook, contributing to a nuanced understanding of Aspen’s position in the pharmaceutical industry.

CNBC Africa – Closing Bell

Sean Capazorio | Godfrey Mutizwa

In a breaking news announcement on CNBC Africa, Godfrey Mutizwa shared new of Aspen’s significant Aspenovax announcement. This pivotal development shed light on Aspen’s innovative contributions to the global fight against COVID-19, impacting vaccine accessibility and public health.

CNBC Africa – Closing Bell

Sean Capazorio | Godfrey Mutizwa

Godfrey Mutizwa and Stephen Saad delved into Aspen’s interim results for 2021. Their discussion covered financial performance, market dynamics, and strategic initiatives, providing viewers with key insights into Aspen’s position and prospects in the pharmaceutical landscape.

12 February 2022
Economic Diplomacy (Global) Ubuntu Award Acceptance
Aspen Pharmacare's receipt of the Economic Diplomacy Global Award at the 6th Ubuntu Awards is a testament to its exemplary contributions in fostering economic relations. This recognition underscores Aspen's commitment to diplomacy and collaborative efforts in advancing global economic prosperity.

The Nielsen Network: C-Suite

Stephen Saad | Bronwyn Nielsen

Stephen Saad discussed Aspen’s financial performance, strategic initiatives, and the pharmaceutical landscape, offering key insights for investors and stakeholders.

Newzroom Afrika

Stephen Saad | Xolani Mbanjwa

Aspen’s significant deal with J&J to distribute COVID-19 vaccines across Africa and its interim results took centre stage. The discussion likely explored the strategic implications of the collaboration and provided insights into Aspen’s financial performance.

eNCA: South Africa Tonight

Stephen Saad | Devan Murugan

Devan Murugan engaged in a discussion on Aspen’s interim results with Stephen Saad. The dialogue provided valuable insights into the company’s financial performance and strategic outlook, contributing to a nuanced understanding of Aspen’s position in the pharmaceutical industry.

CNBC Africa – Closing Bell

Sean Capazorio | Godfrey Mutizwa

In a breaking news announcement on CNBC Africa, Godfrey Mutizwa shared new of Aspen’s significant Aspenovax announcement. This pivotal development shed light on Aspen’s innovative contributions to the global fight against COVID-19, impacting vaccine accessibility and public health.

CNBC Africa – Closing Bell

Sean Capazorio | Godfrey Mutizwa

Godfrey Mutizwa and Stephen Saad delved into Aspen’s interim results for 2021. Their discussion covered financial performance, market dynamics, and strategic initiatives, providing viewers with key insights into Aspen’s position and prospects in the pharmaceutical landscape.

30 November - 1 December 2021
Aspen | Johnson & Johnson non-binding term sheet for Aspenovax
Aspen's Gqeberha vaccine production facility is a beacon of progress in pharmaceutical manufacturing. Its establishment marks a significant stride in the global effort to enhance vaccine accessibility and underscores Aspen's dedication to creating a healthier, more resilient world. This facility not only reflects Aspen's commitment to innovation but also serves as a model for sustainable, community-centric business practices in the pharmaceutical industry.

Aspen Media Briefing

Aspenovax Announcement

Aspen’s media briefing on the launch of Aspenovax showcased a pivotal moment in global health. The panel discussion highlighted the vaccine’s significance, emphasizing Aspen’s role in advancing accessibility and contributing to the fight against COVID-19.

CNN Live: Quest Means Business

Stephen Saad | Richard Quest

The live interview with Stephen Saad delved into the Aspen-J&J term sheet for Aspenovax. Their discussion provided insights into the strategic collaboration, emphasising its impact on vaccine production and global health efforts.

eNCA

Stephen Saad | Sally Burdett

Sally Burdett and Stephen Saad discussed the J&J term sheet for Aspenovax on November 30, 2021. The conversation explored the strategic implications of this collaboration, providing viewers with insights into Aspen’s role in advancing vaccine production.

The Nielsen Network: C-Suite – The Business of Money

Stephen Saad | Bronwyn Nielsen, Lindsay Williams & Anthony Clark

The Nielsen Network’s “The Business of Money” with Bronwyn Nielsen and Lindsay Williams, featuring Stephen Saad and Anthony Clark on “Strictly Business Podcasts,” provided valuable insights into finance and research. Their discussion covered key market trends, business strategies, and financial analysis, contributing to a comprehensive understanding of the dynamic economic landscape.

BBC World News

 Stavros Nicolaou | Christian Fraser

Christian Fraser engaged with Stavros Nicolaou to discuss Aspenovax. The conversation highlighted the vaccine’s global impact and Aspen’s role in combating the COVID-19 pandemic, contributing to international awareness and understanding of vaccine development efforts.

Newzroom Afrika

Stephen Saad | Xolani Mbanjwa

The discussion with Aspen on the J&J term sheet for Aspenovax, highlighted the pivotal collaboration’s significance in advancing vaccine production and addressing critical healthcare needs amid the ongoing pandemic.

CNBC Closing Bell

 Stavros Nicolaou | Godfrey Mutizwa

Godfrey Mutizwa and Stavros Nicolaou explored the significance of Aspenovax in the fight against COVID-19. Their discussion would have provided key insights into vaccine development and Aspen’s role in global health initiatives.

SABC News: The Globe

 Stavros Nicolaou | Peter Ndoro

Peter Ndoro and Stavros Nicolaou discussed Aspenovax, shedding light on its global impact and Aspen’s pivotal role in vaccine development. This interview contributed to public awareness and understanding of ongoing efforts to combat the pandemic.

CGTV: Africa Live

 Stavros Nicolaou | Julie Sheier

Julie Sheier and Stavros Nicolaou discussed Aspenovax, providing insights into its significance in Africa. Their conversation emphasised Aspen’s role in contributing to COVID-19 vaccine accessibility on the continent.

Vaccine Production Overview

Aspen’s Sterile manufacturing facility in Gqeberha, South Africa

Aspen’s state-of-the-art vaccine production facility in Gqeberha, South Africa, stands as a testament to the company’s commitment to advancing global health. Established in 2022, this cutting-edge facility represents a critical milestone in Aspen’s journey as a leading pharmaceutical manufacturer.

702 & Cape Talk: The Money Show

Stephen Saad | Bruce Whitfield

Bruce Whitfield and Stephen Saad discussed the non-binding term sheet between Aspen and Johnson & Johnson for Aspenovax. Their dialogue delved into strategic implications, showcasing Aspen’s pivotal role in advancing global vaccine production.

Podcast: Strictly Business

Stephen Saad | Lindsay Williams

Bruce Whitfield and Stephen Saad discussed the non-binding term sheet between Aspen and Johnson & Johnson for Aspenovax. Their dialogue delved into strategic implications, showcasing Aspen’s pivotal role in advancing global vaccine production.

SAfm Market Update: Moneyweb

Gus Attridge | Fifi Peters

Gus Attridge and Fifi Peters delved into the J&J-Aspen vaccine deal, shedding light on its implications. The interview provided valuable insights into the collaboration, emphasising Aspen’s role in advancing vaccine accessibility and global health initiatives.

Hot.fm: Hot Business

Gus Attridge | Michael Avery

Gus Attridge and Michael Avery discussed the deal, delving into its strategic impact. The interview provided insights into Aspen’s crucial role in bolstering vaccine production and contributing to global health efforts.

SAfm: Sunrise

Stavros Nicolaou | Stephen Grootes

Stavros Nicolaou and Stephen Grootes explored the J&J-Aspen vaccine deal, offering insights into its significance. The discussion emphasised Aspen’s pivotal role in advancing vaccine accessibility and global health initiatives.

21 October 2021
Opening of Aspen's General Anaesthetics Line, Gqeberha, South Africa
Aspen's Gqeberha vaccine production facility is a beacon of progress in pharmaceutical manufacturing. Its establishment marks a significant stride in the global effort to enhance vaccine accessibility and underscores Aspen's dedication to creating a healthier, more resilient world. This facility not only reflects Aspen's commitment to innovation but also serves as a model for sustainable, community-centric business practices in the pharmaceutical industry.

Highlights Footage

Opening of Aspen’s general anaesthetics manufacturing line

The opening of Aspen’s General Anaesthetics Line in Gqeberha, South Africa, signifies a significant stride in pharmaceutical innovation. This state-of-the-art facility highlights Aspen’s commitment to medical advancements and reinforces its role as a key player in the global healthcare landscape.

Stephen Saad’s Address

Opening of Aspen’s general anaesthetics manufacturing line

Stephen Saad’s address emphasised the facility’s impact on healthcare, innovation, and Aspen’s dedication to advancing pharmaceutical manufacturing and medical solutions on a global scale.

Minister Ebrahim Patel’s Address

Opening of Aspen’s general anaesthetics manufacturing line

Minister Ebrahim Patel’s address highlighted the facility’s importance in advancing pharmaceutical manufacturing and fostering economic growth. His remarks emphasised the collaboration’s impact on job creation and medical innovation, underlining the government’s support for initiatives driving healthcare advancements in the country.

Ribbon Cutting and Plaque Unveiling

Opening of Aspen’s general anaesthetics manufacturing line

The ribbon-cutting and plaque unveiling at Aspen’s General Anaesthetics Line in Gqeberha, South Africa, marked a momentous occasion. This state-of-the-art facility underscores Aspen’s dedication to advancing healthcare, promoting innovation, and contributing to the region’s economic growth.

Newzroom Afrika: The Pulse

Sipha Kema reporting for Newzroom Afrika

During the tour of Aspen’s new facilities, the R3 billion investment showcased their commitment as Africa’s largest pharmaceutical company. This state-of-the-art facility reflects innovation and elevates Aspen’s pivotal role in healthcare.

SABC News

Kim Daniels reporting for SABC News

SABC News covered the inauguration of Aspen’s General Anaesthetics Line in Gqeberha, South Africa, emphasising its impact on local healthcare. The report highlighted Aspen’s contribution to the region’s medical advancements and economic growth.

eNCA

Stephen Saad | Govan Whittles

eNCA’s Govan Whittles reported live and discussed with Stephen Saad the opening of Aspen’s General Anaesthetics Line in Gqeberha, South Africa. The dialogue emphasised Aspen’s commitment to medical advancements and the positive impact on local and global healthcare.

2 September 2021
Opening of Aspen's General Anaesthetics Line, Gqeberha, South Africa
Aspen's Gqeberha vaccine production facility is a beacon of progress in pharmaceutical manufacturing. Its establishment marks a significant stride in the global effort to enhance vaccine accessibility and underscores Aspen's dedication to creating a healthier, more resilient world. This facility not only reflects Aspen's commitment to innovation but also serves as a model for sustainable, community-centric business practices in the pharmaceutical industry.

Highlights Footage

Opening of Aspen’s general anaesthetics manufacturing line

The opening of Aspen’s General Anaesthetics Line in Gqeberha, South Africa, signifies a significant stride in pharmaceutical innovation. This state-of-the-art facility highlights Aspen’s commitment to medical advancements and reinforces its role as a key player in the global healthcare landscape.

Stephen Saad’s Address

Opening of Aspen’s general anaesthetics manufacturing line

Stephen Saad’s address emphasised the facility’s impact on healthcare, innovation, and Aspen’s dedication to advancing pharmaceutical manufacturing and medical solutions on a global scale.

Minister Ebrahim Patel’s Address

Opening of Aspen’s general anaesthetics manufacturing line

Minister Ebrahim Patel’s address highlighted the facility’s importance in advancing pharmaceutical manufacturing and fostering economic growth. His remarks emphasised the collaboration’s impact on job creation and medical innovation, underlining the government’s support for initiatives driving healthcare advancements in the country.

Ribbon Cutting and Plaque Unveiling

Opening of Aspen’s general anaesthetics manufacturing line

The ribbon-cutting and plaque unveiling at Aspen’s General Anaesthetics Line in Gqeberha, South Africa, marked a momentous occasion. This state-of-the-art facility underscores Aspen’s dedication to advancing healthcare, promoting innovation, and contributing to the region’s economic growth.

Newzroom Afrika: The Pulse

Sipha Kema reporting for Newzroom Afrika

During the tour of Aspen’s new facilities, the R3 billion investment showcased their commitment as Africa’s largest pharmaceutical company. This state-of-the-art facility reflects innovation and elevates Aspen’s pivotal role in healthcare.

SABC News

Kim Daniels reporting for SABC News

SABC News covered the inauguration of Aspen’s General Anaesthetics Line in Gqeberha, South Africa, emphasising its impact on local healthcare. The report highlighted Aspen’s contribution to the region’s medical advancements and economic growth.

eNCA

Stephen Saad | Govan Whittles

eNCA’s Govan Whittles reported live and discussed with Stephen Saad the opening of Aspen’s General Anaesthetics Line in Gqeberha, South Africa. The dialogue emphasised Aspen’s commitment to medical advancements and the positive impact on local and global healthcare.

April - July 2021
COVID-19 Vaccine Media Coverage
Aspen played a crucial role in global COVID vaccine coverage. As a key manufacturer, the company contributed significantly to expanding vaccine accessibility, fostering hope in the collective effort to combat the pandemic and save lives worldwide.

eNCA: South Africa Tonight

Stephen Saad | Sally Burdett

26 July 2021

Aspen’s Chief Executive, Stephen Saad, discussed the J&J vaccine release with Sally Burdett. The interview provided insights into Aspen’s pivotal role in vaccine distribution, contributing to the global fight against COVID-19.

CNN: Live

Stephen Saad | Julia Chatterley
7 July 2021

In the CNN Live interview, Julia Chatterley and Aspen discussed the company’s investment in equitable vaccine access for Africa. The dialogue underscored Aspen’s commitment to fostering global health and ensuring widespread accessibility to life-saving vaccines on the continent.

Carte Blanche

Stephen Saad | Bongani Bingwa

25 April 2021

Bongani Bingwa discussed Aspen’s pivotal role in Covid vaccine production with Stephen Saad. Their dialogue highlighted the company’s commitment to global health and its significant contributions to the fight against the pandemic through vaccine manufacturing.

President Ramaphosa addresses the nation on COVID-19 response

30 March 2021

President Ramaphosa expresses gratitude to Aspen for their pivotal role in developing a COVID vaccine solution. The company’s contribution underscores a collaborative effort in safeguarding public health during the pandemic.

The Nielsen Network: C-Suite

Stephen Saad | Bronwyn Nielsen

30 March 2021

On the C-Suite Nielsen Network, Stephen Saad discussed Aspen’s role in the vaccine roll-out. His insights would have underscored the company’s commitment to global health, contributing to the success of vaccine distribution efforts.

SABC News: On Point

Stephen Saad | Nzinga Qunta

30 March 2021

On the C-Suite Nielsen Network, Stephen Saad discussed Aspen’s role in the vaccine roll-out. His insights would have underscored the company’s commitment to global health, contributing to the success of vaccine distribution efforts.

Media Enquiries

Shauneen Beukes
Group Communications Consultant
+27 31 580 8600
+27 82 389 8900
sbeukes@aspenpharma.com

Share on social

Follow on social

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.